The effect of cigarette smoke on gastroduodenal mucosal endogenous prostacyclin level (Experimental and clinical observations)
- 1 November 1986
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 19 (3-4) , 224-232
- https://doi.org/10.1007/bf01966210
Abstract
In our opinion the endogenous prostacyclin (PGI2) is one of the most important natural protective substances in the gastric mucosa. We have, therefore checked in experimental circumstances in rats, as well as in clinical observations in humans, the possible effect of smoking on endogenous gastroduodenal mucosal PGI2 level. The animal experiments seem to verify that cigarette smoke really has an unwanted effect on the gastric mucosa. The target of this action is the endogenous PGI2 content of the mucosa. According to our observations in humans there is a definite tendency toward decreased endogenous PGI2 production in the gastroduodenal mucosa of smokers too.This publication has 33 references indexed in Scilit:
- Gastrointestinal Microbleeding Associated with the Use of Etodolac, Ibuprofen, Indomethacin, and Naproxen in Normal MalesThe Journal of Clinical Pharmacology, 1984
- Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: A comparison with aspirin and naproxenInflammation Research, 1984
- Bioavailability studies with etodolac in dogs and manBiopharmaceutics & Drug Disposition, 1984
- Effect of Water Deprivation on Aspirin Disposition KineticsJournal of Pharmaceutical Sciences, 1983
- Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac1 with several clinically effective anti-inflammatory drugsInflammation Research, 1982
- Prostaglandins, Arachidonic Acid, and InflammationScience, 1980
- Gastrointestinal cytoprotection by prostaglandins.Gut, 1979
- Anti-inflammatory and analgesic properties of etodolic acid in ratsCanadian Journal of Physiology and Pharmacology, 1976
- Etodolic acid and related compounds. Chemistry and antiinflammatory actions of some potent di- and trisubstituted 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acidsJournal of Medicinal Chemistry, 1976
- Investigation of 1,3,4,9-tetrahydro-1-propylpyrano [3, 4-b] indole-1-acetic acid (prodolic acid), a new non-steroidal anti-inflammatory agent, in rats1)Inflammation Research, 1974